Lipikind CV 10mg/75mg Capsule is a combination medication containing Atorvastatin 10mg and Clopidogrel 75mg, indicated for the management of cardiovascular conditions requiring both lipid-lowering and antiplatelet therapy. Atorvastatin, a member of the statin class, functions by inhibiting HMG-CoA reductase, thereby reducing cholesterol synthesis and lowering low-density lipoprotein (LDL) cholesterol levels, which contributes to the prevention of atherosclerosis and related cardiovascular events. Clopidogrel, an antiplatelet agent, irreversibly inhibits the P2Y12 component of ADP receptors on platelet surfaces, preventing platelet aggregation and reducing the risk of thrombotic events such as myocardial infarction and stroke. Lipikind CV is primarily prescribed for patients with a history or high risk of coronary artery disease, acute coronary syndrome, or peripheral arterial disease where dual action on lipid control and platelet inhibition is warranted. The combination therapy enhances patient compliance by simplifying the medication regimen. It is essential to monitor liver function tests and complete blood counts periodically during treatment. Caution is advised in patients with active bleeding, hepatic impairment, or hypersensitivity to either component. Consultation with a healthcare professional is recommended before initiating therapy to assess suitability and potential drug interactions.